Citation Impact
Citing Papers
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
2018
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
2011
The gut mycobiome of the Human Microbiome Project healthy cohort
2017 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
2018 Standout
The Prevalence of Intestinal Parasites Is Not Greater Among Individuals With Irritable Bowel Syndrome: A Population-based Case-control Study
2014
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
From non-A, non-B hepatitis to hepatitis C virus cure
2015
Antibiotic resistance andcagAgene correlation: A looming crisis ofHelicobacter pylori
2012
Burden of liver diseases in the world
2018 Standout
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Epidemiology of chronic kidney disease: an update 2022
2022 Standout
Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity
2014
Hepatitis D: Scenario in the Asia-Pacific region
2010
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010
2015 Standout
Irritable bowel syndrome
2016 Standout
Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: a systematic review and meta-analysis
2017
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study
2014
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
2016
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Global burden of liver disease: 2023 update
2023 Standout
Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway
2016
Variable geographic distribution of Blastocystis subtypes and its potential implications
2013
Randomized Comparison of Two Nonbismuth-Containing Rescue Therapies for Helicobacter pylori
2011
Additional corpus biopsy enhances the detection of Helicobacter pylori infection in a background of gastritis with atrophy
2012
Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes
2011
New insights into the pathogenesis and treatment of irritable bowel syndrome
2017
Chronic Kidney Disease
2016 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults
2015
Irritable Bowel Syndrome
2015 Standout
Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment
2010
Chronic Kidney Disease Diagnosis and Management
2019 Standout
The Efficacy of Second‐Line Anti‐Helicobacter pylori Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study
2012
L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy
2017
New Insights on Classification, Identification, and Clinical Relevance ofBlastocystisspp
2008 Standout
Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces
2008
Treatment of Chronic Hepatitis D Patients with Pegylated Interferon: A Real-World Experience
2013
Magmatism at rift zones: The generation of volcanic continental margins and flood basalts
1989 Standout
Jurassic to Paleogene: Part 2 Paleogene geochronology and chronostratigraphy
1985
Characteristics of patients with definite septic arthritis at Hamad General Hospital, Qatar: a hospital-based study from 2006 to 2011
2013
Inhibitory Effects of Respiration Inhibitors on Aflatoxin Production
2014 StandoutNobel
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
2015
Works of Muhammad Islam being referenced
Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan
2006
Role of rapid urease test and histopathology in the diagnosis of Helicobacter pylori infection in a developing country
2005
Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome
2014
Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria
2010
Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan
2005
Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole for Patients Who Failed to Eradicate Helicobacter pylori with Triple Therapy
2008
Estimation of GFR in South Asians: A Study From the General Population in Pakistan
2013
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
2014
Dinoflagellate age of the boundary between Ieper and Panisel Formations (Early Eocene) at Egem, Belgium, and its significance
1982
Comparison of biopsy-based methods for the detection of Helicobacter pylori infection
2006
In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome
2004
Septic arthritis in a tertiary care hospital.
2006
Dinoflagellate Cyst Taxonomy and Biostratigraphy of the Eocene Bracklesham Group in Southern England
1983
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
2011
Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis
2010
IRRITABLE BOWEL SYNDROME: IN SEARCH OF AN ETIOLOGY: ROLE OF BLASTOCYSTIS HOMINIS
2004
Prevalence and mode of spread of hepatitis B and C in rural Sindh, Pakistan.
2009
Phloroglucinol in irritable bowel syndrome.
2006